neoplasia its development mechanisms and neoplastic diseases
TRANSCRIPT
![Page 1: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/1.jpg)
Neoplasia and Neoplastic DiseasesFaraza Javed
M.Phil Pharmacology
![Page 2: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/2.jpg)
Neoplasia
Neoplasia is defined as:
" An abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of the normal tissues and persists in the same excessive manner after cessation of the stimuli that evoked the change."
![Page 3: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/3.jpg)
![Page 4: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/4.jpg)
One in three people in the Western world develop cancer and one in five die of the disease.
There are approximately 200 types of cancer, each with different causes, symptoms and treatments.
In 2007, 297,991 people were newly diagnosed with cancer in the UK.
An individual's risk of developing cancer depends on many factors, including age, lifestyle and genetic make-up.
![Page 5: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/5.jpg)
Causes of Neoplasia
Neoplasia results due to: Genetics Environmental Causes
![Page 6: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/6.jpg)
Genetics: A change in the DNA sequence that can be inherited
from either parent (Inherited) OR A change in the DNA sequence in cells other than
sperm or egg (Somatic)
![Page 7: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/7.jpg)
Somatic
InheritedBoth
Only 5 –10% of cancer cases have a clear hereditary component. Even in those cases where susceptibility is clearly inherited, somatic changes are required for cancer to develop.
![Page 8: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/8.jpg)
External Causes: UV Radiations X-Rays Tobacco Smoke Alcohol Fatty Food Human Papilloma Virus (HPL) Human Immunodeficiency Virus (HIV)
![Page 9: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/9.jpg)
Nomenclature
In common medical usage, a neoplasm often is referredto as a Tumor, and the study of tumors is called Oncology.
Among tumors, the division of neoplasms into Benign and Malignant categories is based on a judgment of a tumor’s potential clinical behaviour.
![Page 10: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/10.jpg)
1. Benign Tumor:Attaching the suffix-oma to the cell of organ and derived tissue cell + oma/ cell + morphologic character + oma
e.g. adenoma of thyroid, ovarian cyst adenoma.
![Page 11: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/11.jpg)
2. Malignant Tumor:Malignant tumors are collectively referred to as Cancers. These are classified as Carcinoma and Sarcoma.
![Page 12: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/12.jpg)
Carcinoma:Malignant tumors of Epithelial cell origin/ name of
organ and derived tissue/ cell + morphologic feature + carcinoma
e.g. adenocarcinoma of thyroid, ovarian cyst adenocarcinoma.
![Page 13: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/13.jpg)
Sarcoma:Malignant tumors arising in Mesenchymal tissue (other than epithelial cell) or its derivatives / The name of organ and derived tissue/ cell + sarcoma
e.g. Angiosarcoma.
![Page 14: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/14.jpg)
![Page 15: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/15.jpg)
3. Teratomas: Tumors containing mature or immature cells or tissues representative of more than one germ layer and sometimes all the three layers.
e.g. Ovarian Teratoma
![Page 16: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/16.jpg)
4. Hamartoma: Tumor-like malformation composed of a haphazard arrangement of tissues indigenous to the particular site, which is totally benign.
e.g. Pulmonary Hamartoma
![Page 17: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/17.jpg)
5. Mixed tumors:
Tumors which derived from one germ layer may
undergo divergent differentiation (involve more than 1
type of tissue) creating so called mixed tumor.
e.g. Mixed tumor of salivary gland and Parotid gland.
![Page 18: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/18.jpg)
![Page 19: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/19.jpg)
Characteristics of Neoplasm
There are four fundamental features by which benign and malignant tumors can be distinguished: Differentiation and Anaplasia Rate of growth Local invasion Metastasis
![Page 20: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/20.jpg)
Differentiation And AnaplasiaDifferentiation- Extent to which neoplastic cell resemble normal cell.
Anaplasia- Lack/ Loss of (structural and functional) Differentiation of normal cell.
Dysplasia- Disordered Growth. Loss in the uniformity of individual cell and their architectural orientation. It represents a state b/w hyperplasia and carcinoma. Does not necessarily progress to cancer.
![Page 21: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/21.jpg)
Benign tumors resemble the tissue of origin and are well differentiated.
Malignant tumors are poorly or completely undifferentiated (anaplstic).
![Page 22: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/22.jpg)
![Page 23: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/23.jpg)
Rate of Growth Benign tumors are slow growing, whereas malignant
tumors generally grow faster.
![Page 24: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/24.jpg)
Local Invasion
A Benign neoplasm remains localized at its site of origin. It does not have the capacity to infiltrate, invade or metastasize to distant site. Most of tumor develop an enclosing fibrous capsule that separates them from the host tissue.
![Page 25: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/25.jpg)
Cancer grow by progressive infiltration, invasion and penetration of surrounding tissue. They do not develop well defined capsule.
Next to the development of metastases, local invasiveness is the most reliable feature that distinguishes malignant from benign tumor.
![Page 26: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/26.jpg)
![Page 27: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/27.jpg)
Metastasis Metastasis are secondary implants discontinuous with
the primary tumor and located in remote tissues.
Benign tumor remain localized to the site of origin, whereas malignant tumor locally invasive and metastasize to distant site.
![Page 28: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/28.jpg)
![Page 29: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/29.jpg)
Molecular Basis of Cancer
![Page 30: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/30.jpg)
Cell CycleThe process of replicating DNA and dividing a cell can be described as a series of coordinated events that compose a “cell division cycle.’’
A set of checkpoints that monitor completion of critical events, leading to cell division and duplication that produce two daughter cells.
![Page 31: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/31.jpg)
1st type of cell cycle regulation, checkpoint control, is more supervisory. Cell cycle checkpoints sense flaws in critical events such as DNA replication and chromosome segregation. When checkpoints are activated, for example by underreplicated or damaged DNA, signals are relayed to the cell cycle-progression machinery. These signals cause a delay in cycle progression, until the danger of mutation has been averted.
![Page 32: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/32.jpg)
![Page 33: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/33.jpg)
![Page 34: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/34.jpg)
2nd is the cascade of protein phosphorylations that relay a cell from one stage to the next. Cyclin-dependent kinases (CDKs) are a family of protein kinases discovered for their role in regulating the cell cycle. They are also involved in regulating transcription, mRNA processing, and the differentiation of cells. CDK binds a regulatory protein called a cyclin, form cyclin-CDK complex and phosphorylate their respective substrate and regulate cell cycle.
![Page 35: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/35.jpg)
Receptors Protein Function
CDK1 Cyclin A Regulate all cell cycle stages
Cyclin B M phase
CDK2 Cyclin A All cell stages, G2 phase
Cyclin E S phase
Cyclin D G1 phase
![Page 36: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/36.jpg)
![Page 37: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/37.jpg)
Regulatory phosphorylation and dephosphorylation fine-tune the activity of CDK–cyclin complexes, ensuring well-delineated transitions between cell cycle stages.
Mutation or deregulation of this process has been associated with many types of cancers i.e. uncontrolled cell proliferation. Hence, CDKs are considered as a potential target for anti-cancer medication.
![Page 38: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/38.jpg)
Molecular Basis of CancerCarcinogenesis is a multistep process resulting from the accumulation of multiple genetic alterations that collectively give rise to the transformed phenotype. DNA Repair Gene Oncogenes Tumor Suppressor Gene Genes Regulating Apoptosis
![Page 39: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/39.jpg)
DNA Repair Gene DNA repair genes code for proteins whose normal
function is to correct errors that arise when cells duplicate their DNA prior to cell division.
DNA repair genes are active throughout the cell cycle, particularly during G2 after DNA replication and before the chromosomes divide.
![Page 40: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/40.jpg)
Mutations in DNA repair genes can lead to a failure in repair, which in turn allows subsequent mutations to accumulate.
If the rate of DNA damage exceeds the capacity of the cell to repair it, the accumulation of errors can overwhelm the cell and result in cancer.
A few important DNA repair genes include BRCA1 and BRCA2 gene.
![Page 41: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/41.jpg)
Oncogenes An oncogene is a proto-oncogene that has been
mutated in a way that leads to signals that cause uncontrolled growth.
Oncogenes are "gain of function" genes. They gain the ability to drive non-stop growth. In spite of their dominant activities, a single mutated oncogene usually isn't enough to cause cancer all by itself because tumor-suppressor genes are acting to put the brakes on to keep cell growth from getting out of control.
![Page 42: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/42.jpg)
Oncogenes aren't usually involved in inherited forms of cancer because most occur as somatic mutations and can't be passed from parent to child.
Example of Oncogenes include HER-2, RAS, SRC, hTERT.
![Page 43: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/43.jpg)
Tumor Suppressor Gene
Tumor suppressor genes in normal cells act as braking signals during phase G1 of the cell cycle, to stop or slow the cell cycle before S phase. If tumor-suppressor genes are mutated, the normal brake mechanism will be disabled, resulting in uncontrolled growth, i.e. cancer.
![Page 44: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/44.jpg)
Mutations in tumor-suppressor genes cause loss-of-function. Loss-of-function mutations generally only show up when both copies of the gene are mutated. In other words, if a pair of tumor suppressor genes are lost or mutated, their functional absence might allow cancer to develop.
Individuals who inherit an increased risk of developing cancer often are born with one defective copy of a tumor suppressor gene.
![Page 45: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/45.jpg)
Because genes come in pairs (one inherited from each parent), an inherited defect in one copy will not lead to cancer because the other normal copy is still functional. But if the second copy undergoes mutation, the person then may develop cancer because there is no longer any functional copy of the gene.
P53, Rb, APC are few examples of tumor suppressor genes.
![Page 46: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/46.jpg)
Genes Regulating ApoptosisApoptosis is the death of cells which occurs as a normal and controlled part of an organism's growth or development.
Mutations of these genes that regulate apoptosis result in evasion of Apoptosis, would also be a factor in carcinogenesis.
Genes involve in regulation of Apoptosis include BCL2, p53 and MYC.
![Page 47: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/47.jpg)
Hall Marks of Cancer
Each cancer gene has a specific function, the dysregulation of which contributes to the origin or progression of malignancy. It is best, therefore, to consider cancer related genes in the context of several fundamental changes in cell physiology, the socalled hallmarks of cancer, which together dictate the malignant phenotype.
![Page 48: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/48.jpg)
![Page 49: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/49.jpg)
Self-Sufficiency of Growth Signals
Normal cells require external growth signals (growth factors) to grow and divide. These signals are transmitted through receptors that pass through the cell membrane. When the growth signals are absent, cell stop growing.Cancer cells do not need stimulation from external signals (in the form of growth factors) to multiply.Cancer cells can grow and divide without external growth signals.
![Page 50: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/50.jpg)
The best documented examples of over expression involve the epidermal growth factor (EGF) receptor family. These signaling proteins couple growth factor receptors to their nuclear targets. They receive signals from activated growth factor receptorsand transmit them to the nucleus, either through second messengers or through a cascade of phosphorylation and activation of signal transduction molecules.
![Page 51: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/51.jpg)
Two important members in this category are RAS and ABL.
RAS is a member of a family of small G proteins that bind [GTP] and [GDP], similar to thelarger trimolecular G proteins. Due to mutation RAS is locked into its active GTP form and the cell is forced into a continuous proliferating state.
![Page 52: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/52.jpg)
Activated ras then causes the activation of a cellular kinase called RAF1. RAF1 kinase then phosphorylates another cellular kinase called MEK. This cause the activation of MEK. Activated MEK then phosphorylates another protein kinase called MAPK causing its activation i.e MAP Kinase Pathway and ultimately causes changes in gene transcription.
RAF and MEK are targeted sites for anti cancer drugs.
![Page 53: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/53.jpg)
![Page 54: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/54.jpg)
Insensitivity to Anti-Growth Signal
The growth of normal cells is kept under control by growth inhibitors in the surrounding environment, in the extracellular matrix and on the surfaces of neighboring cells. These inhibitors act on the cell cycle clock, by interrupting cell division in the interphase.
Cancer cells are generally resistant to these growthpreventing signals.
![Page 55: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/55.jpg)
Evading Apoptosis Cells are born, live for
a given period of time and then die
APOPTOSIS
Physiological cell death Cell suicide Cell deletion
Programmed cell death
![Page 56: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/56.jpg)
When ligand bind to receptor tyrosine kinase, receptor get activation and this signaling activates PI3K which catalyses phosphorylation of inositol phosphates (PIP2 to PIP3). These act as second messengers and recruit molecules such as Akt kinase to the cell membrane. AKT Kinase phosphorylate BAD and Forkhead Proteins that promote cell survival.
![Page 57: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/57.jpg)
BAD (Proapoptotic Protein) is activated when it is non phosphorylated and hence cause apoptosis. AKT causes phosphorylation of BAD that results in antiapoptotic effect.
Receptor Tyrosine Kinase Inhibitors or more precisely AKT inhibitors are now developed as an anticancer agents.
![Page 58: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/58.jpg)
![Page 59: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/59.jpg)
Limitless Replicative Potential
Mammalian cells have an intrinsic program, the Hayflick Limit, that limits their multiplication to a certain limit.
This limit can be overcome by disabling their pRB and p53 tumor suppressor proteins, which allows them to continue doubling until they reach a stage called crisis that results in emergence of an immortalized cell that can double without limit.
![Page 60: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/60.jpg)
The counting device for cell doublings is the telomere, which loses DNA at the tips of every chromosome during each cell cycle. Many cancers involve the up regulation of telomerase, the enzyme that maintains telomeres.
![Page 61: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/61.jpg)
Sustained Angiogenesis Angiogenesis is the growth of blood vessels from the
existing vasculature. It is also a fundamental step in the transition of tumors from a dormant state to a malignant one.
Tumors cannot grow beyond a certain size, generally 1–2 mm3, due to a lack of oxygen and other essential nutrients. HIF1(Hypoxia inducible factor) act as a transcription factor to activate the GF.
![Page 62: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/62.jpg)
To supply nutrients and oxygen, tumors induce blood vessel growth (angiogenesis) by secreting various growth factors (e.g. VEGF). Growth factors such as bFGF and VEGF can induce capillary growth into the tumor.
Angiogenesis is involved in the growth of cervix, breast and melanoma tumors. AntiVEGF antibodies slowed the growth of tumors in mice. Antiangiogenesis compounds are under investigation as drugs to treat cancer.
![Page 63: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/63.jpg)
Tissue Invasion and MetastasisCancer cells can break away from their site or organ of origin to invade surrounding tissue and spread (metastasize) to distant body parts.
Normal cell–cell interactions is regulated, through Cell–cell adhesion molecules (CAMs) Integrins
![Page 64: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/64.jpg)
CAM and Integrin becomes altered and results in metastases as in lung cancer and colorectal cancer and allow Primary tumor masses spawn "pioneer cells" that invade adjacent tissues, and may then travel to distant sites to establish metastases.
![Page 65: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/65.jpg)
Neoplastic Diseases
![Page 66: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/66.jpg)
Lungs Cancer Lung cancer is the number one cancer killer of men
and women. Most cases of lung cancer are related to cigarette smoking. Cancer may be caused by acombination of genetic factorsand exposure to radon gasor other forms of air pollutionincluding secondhand smoke.
![Page 67: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/67.jpg)
Symptoms Persistent Cough Blood-streaked Sputum Chest Pain Fever Fatigue Wheezing and Shortness of Breath Pneumonia
![Page 68: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/68.jpg)
Treatment
Chemotherapy Radiotherapy Surgery
![Page 69: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/69.jpg)
Breast CancerCancer of the breast is the 2nd leading cause of cancer deaths in women.
Risk factors for developing breast cancer include: Obesity Alcohol Consumption Hormone Replacement Therapy Ionizing Radiation and Having Children late or not at all
![Page 70: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/70.jpg)
Symptoms
Lump in the breast Dimpling of skin Skin irritation Red Scaly Patch on Skin Swollen Lymph Nodes Constant Pain in breast and armpit area
![Page 71: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/71.jpg)
Treatment
Lumpectomy Radical Mastectomy Chemotherapy Hormone Blocking Therapy Monoclonal Antibodies Radiotherapy
![Page 72: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/72.jpg)
Colon and Rectal Cancers
Third most common cancers in men and women but 90% of colorectal cancers are preventable.
Risk factors: Age over 50 years, obesity, family history of colon or rectal cancer, diet high in fats and low in fiber, smoking, high alcohol consumption, lack of exercise, inflammatory bowel disease and ulcerative colitis.
It typically starts as a benign tumor which over time becomes cancerous.
![Page 73: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/73.jpg)
Symptoms
Nausea and Vomiting Change in bowel movements Loss of appetite Blood in Stool Worsening Constipation Weight Loss
![Page 74: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/74.jpg)
Treatment
Chemotherapy Radiotherapy Surgery
![Page 75: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/75.jpg)
Skin CancerLong-term sun exposure (UV Radiations) can result in skin cancer. Malignant melanoma is the deadliest form of skin cancer.
Use the ABCD rule to detect melanoma. Asymmetry: Half of a mole does not look like the
other half Border irregularity: The edges are uneven Color: Pigmentation is not uniform Diameter: Larger than a pea
![Page 76: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/76.jpg)
Treatment
Chemotherapy Surgery Skin Grafting
![Page 77: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/77.jpg)
Prostate CancerProstate cancer is the carcinoma of prostate gland that may spread to other parts of the body particularly bones and lymph nodes.
Symptoms: Weak or interrupted urine flow Blood in urine Nocturia, Dysuria Pain in Pelvis
![Page 78: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/78.jpg)
Treatment
Chemotherapy Radiotherapy Prostectomy
![Page 79: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/79.jpg)
LeukemiaLeukemia is a group of cancers that usually begins in the bone marrow and results in high number of abnormal white blood cells. There are 4 main types of leukemia: Acute Lymphoblastic Leukemia (ALL) Acute Myeloid Leukemia (AML) Chronic Lymphoblastic Leukemia (CLL) Chronic Myeloid Leukemia (CML)
![Page 80: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/80.jpg)
Symptoms Bleeding and Bruising Problems Lack of Blood Platelets Pinprick Bleeds (Petechiae) on Skin Anemia Swollen Lymph Nodes Weight Loss Opportunistic Infections
![Page 81: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/81.jpg)
Treatment
Chemotherapy Radiotherapy Bone marrow transplantation
![Page 82: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/82.jpg)
Cancer’s Seven Warning Signals
![Page 83: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/83.jpg)
Awareness ProgramsRibbon Awareness Campaign
You can be a victim of cancer or a survivor of cancer.
It’s a mindset.
![Page 84: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/84.jpg)
Hope is the Physician of Each Misery
![Page 85: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/85.jpg)
![Page 86: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/86.jpg)
References Robbins Basic Pathology, 9th Edition. Kopnin, B. P.Targets of oncogenes and tumor suppressors:
key for understanding basic mechanisms of carcinogenesis. Biokhimiya 65, 2–27 (2000).
Hahn, W. C. & Weinberg, R. A. Rules for making human tumor cells. New England Journal of Medicine 347, 1593–1603.
Bric, A., Miething, C. et al. Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model.Cancer Cell 16, 324–335 (2009).
![Page 87: Neoplasia its Development Mechanisms and Neoplastic diseases](https://reader034.vdocument.in/reader034/viewer/2022052400/55a3da8b1a28abc7138b45b3/html5/thumbnails/87.jpg)
Hallmarks of Cancer, Cancer Research UK Science Update blog, November 2010.
Lazebnik Y (April 2010). "What are the hallmarks of cancer?". Nat. Rev. Cancer 10(4): 232–3.
Hams NL, Jaffa ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International (2010); 84: 1361-92.